PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26771508-6	2016	The prepared Her-Fe3O4@PLGA-PVP nanocomposites facilitate packing of anticancer drug (Tamoxifen) without premature release in the bloodstream, recognizing the target cells through binding of Herceptin antibody to HER2, a cell surface receptor expressed by breast cancer cells to promote HER2 receptor mediated endocytosis and finally releasing the drug at the intracellular site of tumor cells ("On" state) to induce apoptosis.	ferryl iron	17-22	erb-b2 receptor tyrosine kinase 2	Homo sapiens	213-217	
31669845-11	2020	Ultimately, trastuzumab (anti HER-2) antibody has been used to test the performance of the prepared Fe3O4@Pd/CaCO3-DTT NPs in a real protein reduction reaction.	ferryl iron	100-105	erb-b2 receptor tyrosine kinase 2	Homo sapiens	30-35	
26771508-6	2016	The prepared Her-Fe3O4@PLGA-PVP nanocomposites facilitate packing of anticancer drug (Tamoxifen) without premature release in the bloodstream, recognizing the target cells through binding of Herceptin antibody to HER2, a cell surface receptor expressed by breast cancer cells to promote HER2 receptor mediated endocytosis and finally releasing the drug at the intracellular site of tumor cells ("On" state) to induce apoptosis.	ferryl iron	17-22	erb-b2 receptor tyrosine kinase 2	Homo sapiens	287-291	
34778301-1	2021	Objective: The purpose of this study was to investigate the anticancer activity and the potential imaging use of the innovative combination of magnetic nanoparticles (MNPs)-Fe3O4, paclitaxel (PTX), and trastuzumab (Herceptin) in HER2-positive breast cancer.	ferryl iron	173-178	erb-b2 receptor tyrosine kinase 2	Homo sapiens	229-233	
24734871-3	2014	The MFNPs contain a well-defined core-shell structure of UCNP@Fe3O4@Au coated by poly(ethylene glycol) (PEG) and anti-HER2 antibody, displaying excellent dispersity in various aqueous solutions.	ferryl iron	62-67	erb-b2 receptor tyrosine kinase 2	Homo sapiens	118-122